Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.

Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.

The filoviruses, Marburg virus (MARV) and Ebola virus, causes severe hemorrhagic fever with high mortality in humans and nonhuman primates. A promising filovirus vaccine under development is based on a recombinant vesicular stomatitis virus (rVSV) that expresses individual filovirus glycoproteins (G...

Full description

Bibliographic Details
Main Authors:	Chad E Mire, Joan B Geisbert, Krystle N Agans, Benjamin A Satterfield, Krista M Versteeg, Elizabeth A Fritz, Heinz Feldmann, Lisa E Hensley, Thomas W Geisbert
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3997383?pdf=render

Similar Items

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013-01-01)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
by: Chad E. Mire, et al.
Published: (2019-06-01)

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.
by: Thomas W Geisbert, et al.
Published: (2008-11-01)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
by: Courtney Woolsey, et al.
Published: (2022-05-01)

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
by: Christopher L. Cooper, et al.
Published: (2022-09-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Andrea Marzi, et al.
Published: (2015-02-01)

Postexposure Treatment of Marburg Virus Infection
by: Thomas W. Geisbert, et al.
Published: (2010-07-01)

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
by: David Safronetz, et al.
Published: (2015-04-01)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
by: Andrea R. Menicucci, et al.
Published: (2017-10-01)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
by: Robert W. Cross, et al.
Published: (2023-03-01)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
by: Courtney Woolsey, et al.
Published: (2023-02-01)

Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
by: Sergio E. Rodriguez, et al.
Published: (2019-05-01)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
by: Thomas W. Geisbert, et al.
Published: (2002-05-01)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
by: Robert W. Cross, et al.
Published: (2022-05-01)

Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.
by: Thomas W Geisbert, et al.
Published: (2010-05-01)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)

Computed Tomography Imaging for Monitoring of Marburg Virus Disease: a Nonhuman Primate Proof-Of-Concept Study
by: Jennifer Sword, et al.
Published: (2023-06-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells
by: Reed S. Shabman, et al.
Published: (2014-12-01)

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccineResearch in context
by: Kyle L. O'Donnell, et al.
Published: (2023-03-01)

Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates
by: Courtney Woolsey, et al.
Published: (2024-12-01)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
by: Ellen Suder, et al.
Published: (2018-09-01)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
by: Takeshi Saito, et al.
Published: (2020-08-01)

Viruses from Nonhuman Primates
by: Regis A. Vilchez
Published: (2006-11-01)

The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway
by: Megan R. Edwards, et al.
Published: (2014-03-01)

Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
by: Joseph Prescott, et al.
Published: (2014-01-01)

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.
by: Nancy J Sullivan, et al.
Published: (2006-06-01)

Influenza Virus Infection in Nonhuman Primates
by: Erik A. Karlsson, et al.
Published: (2012-10-01)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
by: Igor Morozov, et al.
Published: (2021-01-01)

THE NEUTRALIZING ANTIBODY-RESPONSE AGAINST VESICULAR STOMATITIS-VIRUS
by: Zinkernagel, R, et al.
Published: (1995)

Atomic model of vesicular stomatitis virus and mechanism of assembly
by: Kang Zhou, et al.
Published: (2022-10-01)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
by: Lamin B. Cham, et al.
Published: (2019-09-01)

Structure of the vesicular stomatitis virus N⁰-P complex.
by: Cédric Leyrat, et al.
Published: (2011-09-01)

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge
by: Courtney Woolsey, et al.
Published: (2019-09-01)

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses.
by: George G Daaboul, et al.
Published: (2017-01-01)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
by: Bolni Marius Nagalo, et al.
Published: (2020-09-01)

Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin.
by: Nirav R Shah, et al.
Published: (2010-06-01)

Cellular microRNAs Repress Vesicular Stomatitis Virus but Not Theiler’s Virus Replication
by: Aurélie De Cock, et al.
Published: (2016-03-01)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01)

Depletion and reconstitution of macrophages in mice with vesicular stomatitis virus infection
by: Yingchun Wang, et al.
Published: (2023-06-01)